FDA issued a Warning Letter to Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy on 2/27/2018 for a previous inspection.
483 Snyder Mark Drugs Roselle d.b.a. Mark Drugs Pharmacy Sep 2019

483 Snyder Mark Drugs Roselle d.b.a. Mark Drugs Pharmacy Sep 2019

Anthony Ladner FDA, Norman Starks FDA$119.00 - Available Now

FDA investigators audited the Snyder Mark Drugs Roselle d.b.a. Mark Drugs Pharmacy - Roselle, IL, United States facility and issued inspectional observations (via FDA 483) on 27 Sep 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 27 Sep 2019
  • Location: Roselle, United States
  • FEI: 3004486825
Add To Cart